{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:54:49Z","timestamp":1787241289130,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 ES026219"],"award-info":[{"award-number":["RO1 ES026219"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5P01CA210946"],"award-info":[{"award-number":["5P01CA210946"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10753-022-01629-w","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T17:02:27Z","timestamp":1647536547000},"page":"1388-1401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ex Vivo Culture Models of Hidradenitis Suppurativa for Defining Molecular Pathogenesis and Treatment Efficacy of Novel Drugs"],"prefix":"10.1007","volume":"45","author":[{"given":"Kayla F.","family":"Goliwas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra P.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen S. W.","family":"Oak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatram","family":"Atigadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Elmets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Shahid","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chander","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6761-5662","authenticated-orcid":false,"given":"Jessy S.","family":"Deshane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Athar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"1629_CR1","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","volume":"153","author":"A Garg","year":"2017","unstructured":"Garg, A., J.S. Kirby, J. Lavian, G. Lin, and A. Strunk. 2017. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA dermatology 153: 760\u2013764.","journal-title":"JAMA dermatology"},{"key":"1629_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41702-019-0052-0","volume":"4","author":"K Phan","year":"2020","unstructured":"Phan, K., O. Charlton, and S.D. Smith. 2020. Global prevalence of hidradenitis suppurativa and geographical variation\u2014Systematic review and meta-analysis. Biomedical Dermatology 4: 2.","journal-title":"Biomedical Dermatology"},{"key":"1629_CR3","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/exd.13978","volume":"28","author":"JW Frew","year":"2019","unstructured":"Frew, J.W., K. Navrazhina, M. Marohn, P.C. Lu, and J.G. Krueger. 2019. Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa\/acne inversa. Experimental dermatology 28: 886\u2013891.","journal-title":"Experimental dermatology"},{"key":"1629_CR4","doi-asserted-by":"crossref","unstructured":"Guenin-Mace, L., J.D. Morel, J.M. Doisne, A. Schiavo, L. Boulet, V. Mayau, P. Goncalves, S. Duchatelet, A. Hovnanian, V. Bondet, et al. 2020. Dysregulation of tryptophan catabolism at the host-skin microbiota interface in hidradenitis suppurativa. JCI Insight 5: e140598.","DOI":"10.1172\/jci.insight.140598"},{"key":"1629_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1126\/scitranslmed.aav5908","volume":"11","author":"AS Byrd","year":"2019","unstructured":"Byrd, A.S., C. Carmona-Rivera, L.J. O\u2019Neil, P.M. Carlucci, C. Cisar, A.Z. Rosenberg, M.L. Kerns, J.A. Caffrey, S.M. Milner, J.M. Sacks, et al. 2019. Neutrophil extracellular traps B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa. Science translational medicine 11: 508.","journal-title":"Science translational medicine"},{"key":"1629_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1365-2133.2011.10643.x","volume":"166","author":"HH van der Zee","year":"2012","unstructured":"van der Zee, H.H., L. de Ruiter, J. Boer, D.G. van den Broecke, J.C. den Hollander, J.D. Laman, and E.P. Prens. 2012. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. British Journal of Dermatology 166: 98\u2013106.","journal-title":"British Journal of Dermatology"},{"key":"1629_CR7","first-page":"1547","volume":"72","author":"N Shah","year":"2005","unstructured":"Shah, N. 2005. Hidradenitis suppurativa: A treatment challenge. American family physician 72: 1547\u20131552.","journal-title":"American family physician"},{"key":"1629_CR8","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.jid.2016.04.036","volume":"136","author":"C Hotz","year":"2016","unstructured":"Hotz, C., M. Boniotto, A. Guguin, M. Surenaud, F. Jean-Louis, P. Tisserand, N. Ortonne, B. Hersant, R. Bosc, F. Poli, et al. 2016. Intrinsic defect in keratinocyte function leads to inflammation in hidradenitis suppurativa. Journal of Investigative Dermatology 136: 1768\u20131780.","journal-title":"Journal of Investigative Dermatology"},{"key":"1629_CR9","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.jaci.2020.12.651","volume":"147","author":"K Navrazhina","year":"2021","unstructured":"Navrazhina, K., J.W. Frew, P. Gilleaudeau, M. Sullivan-Whalen, S. Garcet, and J.G. Krueger. 2021. Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa. Journal of Allergy and Clinical Immunology 147: 2213\u20132224.","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"1629_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/bjd.14199","volume":"174","author":"E Sbidian","year":"2016","unstructured":"Sbidian, E., C. Hotz, J. Seneschal, A. Maruani, F. Amelot, F. Aubin, C. Paul, M. Beylot-Barry, P. Humbert, A. Dupuy, et al. 2016. Antitumour necrosis factor-alpha therapy for hidradenitis suppurativa: Results from a national cohort study between 2000 and 2013. British Journal of Dermatology 174: 667\u2013670.","journal-title":"British Journal of Dermatology"},{"key":"1629_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/13543784.2018.1412430","volume":"27","author":"P Theut-Riis","year":"2018","unstructured":"Theut-Riis, P., L.R. Thorlacius, and G.B. Jemec. 2018. Investigational drugs in clinical trials for hidradenitis suppurativa. Expert opinion on investigational drugs 27: 43\u201353.","journal-title":"Expert opinion on investigational drugs"},{"key":"1629_CR12","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","volume":"164","author":"HH van der Zee","year":"2011","unstructured":"van der Zee, H.H., L. de Ruiter, D.G. van den Broecke, W.A. Dik, J.D. Laman, and E.P. Prens. 2011. Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: A rationale for targeting TNF-alpha and IL-1beta. British Journal of Dermatology 164: 1292\u20131298.","journal-title":"British Journal of Dermatology"},{"key":"1629_CR13","doi-asserted-by":"crossref","unstructured":"Lowe, M.M., H.B. Naik, S. Clancy, M. Pauli, K.M. Smith, Y. Bi, R., Dunstan, J.E. Gudjonsson, M. Paul, H. Harris, et al. 2020. Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-alpha therapy. JCI Insight 5: e139932.","DOI":"10.1172\/jci.insight.139932"},{"key":"1629_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/14728214.2020.1787984","volume":"25","author":"AS Folkes","year":"2020","unstructured":"Folkes, A.S., F.Z. Hawatmeh, A. Wong, and F.A. Kerdel. 2020. Emerging drugs for the treatment of hidradenitis suppurativa. Expert Opinion on Emerging Drugs 25: 201\u2013211.","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"1629_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/bjd.18983","volume":"184","author":"AV Marzano","year":"2021","unstructured":"Marzano, A.V., G. Genovese, G. Casazza, C. Moltrasio, P. Dapavo, G. Micali, R. Sirna, P. Gisondi, A. Patrizi, V. Dini, et al. 2021. Evidence for a \u201cwindow of opportunity\u201d in hidradenitis suppurativa treated with adalimumab: A retrospective real-life multicentre cohort study. British Journal of Dermatology 184: 133\u2013140.","journal-title":"British Journal of Dermatology"},{"key":"1629_CR16","doi-asserted-by":"crossref","unstructured":"Frew, J.W., J.E. Hawkes, and J.G. Krueger. 2018. A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa. F1000Research 7: 1930.","DOI":"10.12688\/f1000research.17267.1"},{"key":"1629_CR17","doi-asserted-by":"publisher","first-page":"14167","DOI":"10.1038\/s41598-017-14326-8","volume":"7","author":"KF Goliwas","year":"2017","unstructured":"Goliwas, K.F., J.R. Richter, H.C. Pruitt, L.M. Araysi, N.R. Anderson, R.S. Samant, S.M. Lobo-Ruppert, J.L. Berry, and A.R. Frost. 2017. Methods to evaluate cell growth, viability, and response to treatment in a tissue engineered breast cancer model. Scientific reports 7: 14167.","journal-title":"Scientific reports"},{"key":"1629_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.juro.2013.02.090","volume":"190","author":"M Kashyap","year":"2013","unstructured":"Kashyap, M., N. Kawamorita, V. Tyagi, Y. Sugino, M. Chancellor, N. Yoshimura, and P. Tyagi. 2013. Down-regulation of nerve growth factor expression in the bladder by antisense oligonucleotides as new treatment for overactive bladder. The Journal of urology 190: 757\u2013764.","journal-title":"The Journal of urology"},{"key":"1629_CR19","doi-asserted-by":"crossref","unstructured":"Goliwas, K.F., C.S. Simmons, S.A. Khan, A.M. Wood, Y. Wang, J.L. Berry, M. Athar, J.A. Mobley, Y.I. Kim, V.J. Thannickal, et al. 2021. Local SARS-CoV-2 peptide-specific immune responses in convalescent and uninfected human lung tissue models. medRxiv.","DOI":"10.1101\/2021.09.02.21263042"},{"key":"1629_CR20","doi-asserted-by":"publisher","first-page":"E3993","DOI":"10.1073\/pnas.1700109114","volume":"114","author":"Y Bao","year":"2017","unstructured":"Bao, Y., X. Wu, J. Chen, X. Hu, F. Zeng, J. Cheng, H. Jin, and X., Lin, and L.F. Chen. 2017. Brd4 modulates the innate immune response through Mnk2-eIF4E pathway-dependent translational control of IkappaBalpha. Proceedings of the National Academy of Sciences 114: E3993\u2013E4001.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"1629_CR21","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2015-07-567958","volume":"126","author":"EC Fink","year":"2015","unstructured":"Fink, E.C., and B.L. Ebert. 2015. The novel mechanism of lenalidomide activity. Blood 126: 2366\u20132369.","journal-title":"Blood"},{"key":"1629_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/08820139.2016.1230867","volume":"46","author":"A Banerjee","year":"2017","unstructured":"Banerjee, A., S. McNish, and V.K. Shanmugam. 2017. Interferon-gamma (IFN-gamma) is elevated in wound exudate from hidradenitis suppurativa. Immunological investigations 46: 149\u2013158.","journal-title":"Immunological investigations"},{"key":"1629_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/bjd.16019","volume":"178","author":"S Hessam","year":"2018","unstructured":"Hessam, S., M. Sand, T. Gambichler, M. Skrygan, I. Ruddel, and F.G. Bechara. 2018. Interleukin-36 in hidradenitis suppurativa: Evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop. British Journal of Dermatology 178: 761\u2013767.","journal-title":"British Journal of Dermatology"},{"key":"1629_CR24","doi-asserted-by":"publisher","first-page":"2450401","DOI":"10.1155\/2017\/2450401","volume":"2017","author":"D Jimenez-Gallo","year":"2017","unstructured":"Jimenez-Gallo, D., R. de la Varga-Martinez, L. Ossorio-Garcia, C. Albarran-Planelles, C. Rodriguez, and M. Linares-Barrios. 2017. The clinical significance of increased serum proinflammatory cytokines C-reactive protein and erythrocyte sedimentation rate in patients with hidradenitis suppurativa. Mediators of inflammation 2017: 2450401.","journal-title":"Mediators of inflammation"},{"key":"1629_CR25","doi-asserted-by":"crossref","unstructured":"Kanni, T., V. Tzanetakou, A. Savva, B. Kersten, A. Pistiki, F.L. van de Veerdonk, M.G. Netea, J.W. van der Meer, and E.J. Giamarellos-Bourboulis. 2015. Compartmentalized cytokine responses in hidradenitis suppurativa. PLoS One 10: e0130522.","DOI":"10.1371\/journal.pone.0130522"},{"key":"1629_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/bjd.17641","volume":"181","author":"A Vossen","year":"2019","unstructured":"Vossen, A., C.B. Ardon, H.H. van der Zee, E. Lubberts, and E.P. Prens. 2019. The anti-inflammatory potency of biologics targeting tumour necrosis factor-alpha, interleukin (IL)-17A, IL-12\/23 and CD20 in hidradenitis suppurativa: An ex vivo study. British Journal of Dermatology 181: 314\u2013323.","journal-title":"British Journal of Dermatology"},{"key":"1629_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jdermsci.2020.05.004","volume":"99","author":"L Brandao","year":"2020","unstructured":"Brandao, L., R. Moura, P.M. Tricarico, R. Gratton, G. Genovese, C. Moltrasio, S. Garcovich, M. Boniotto, S. Crovella, and A.V. Marzano. 2020. Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: A novel whole exome sequencing approach. Journal of Dermatological Science 99: 17\u201322.","journal-title":"Journal of Dermatological Science"},{"key":"1629_CR28","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1038\/s41388-019-1124-8","volume":"39","author":"PS Filippou","year":"2020","unstructured":"Filippou, P.S., G.S. Karagiannis, and A. Constantinidou. 2020. Midkine (MDK) growth factor: A key player in cancer progression and a promising therapeutic target. Oncogene 39: 2040\u20132054.","journal-title":"Oncogene"},{"key":"1629_CR29","doi-asserted-by":"crossref","unstructured":"Hoffman, L.K., L.E. Tomalin, G. Schultz, M.D. Howell, N. Anandasabapathy, A. Alavi, M. Suarez-Farinas, and M.A. Lowes. 2018. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature. PLoS One 13: e0203672.","DOI":"10.1371\/journal.pone.0203672"},{"key":"1629_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1357-2725(01)00155-8","volume":"34","author":"SE Jones","year":"2002","unstructured":"Jones, S.E., and C. Jomary. 2002. Clusterin. The international journal of biochemistry & cell biology 34: 427\u2013431.","journal-title":"The international journal of biochemistry & cell biology"},{"key":"1629_CR31","doi-asserted-by":"crossref","unstructured":"Sabat, R., A. Chanwangpong, S. Schneider-Burrus, D. Metternich, G. Kokolakis, A. Kurek, S. Philipp, D. Uribe, K. Wolk, and W. Sterry. 2012. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One 7: e31810.","DOI":"10.1371\/journal.pone.0031810"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01629-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-022-01629-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01629-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T23:50:38Z","timestamp":1652313038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-022-01629-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1629"],"URL":"https:\/\/doi.org\/10.1007\/s10753-022-01629-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1075860\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2021.10.11.464007","asserted-by":"object"}]},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,17]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DECLARATIONS"}},{"value":"The institutional Review Board of the University of Alabama at Birmingham approved the protocol (IRB-300005214) for obtaining surgically removed discarded skin tissues from breast\/tummy reduction from otherwise healthy individuals and HS patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"All authors agree to submit this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}